Y-Intercept »

Aldeyra Therapeutics shares owned by Y-Intercept

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $36k 17k 2.13
2025-09-30 $721k 138k 5.22

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Aldeyra Therapeutics

Knoll Capital Management
AQR Capital Management
Kingdon Capital Management
Vanguard Capital Management
D. E. Shaw & Co
Marshall Wace
683 Capital Management
Jane Street
Ardsley Advisory Partners
BlackRock
Qube Research & Technologies
State Street Corporation
Acadian Asset Management
Renaissance Technologies
Vanguard Portfolio Management

View all funds holding Aldeyra Therapeutics